TympaHealth raises £5.9m in seed funding to accelerate international market expansion
The seed round was led by serial healthcare entrepreneurs Maurice Ferre and Arjun Desai to support expansion across the UK, Europe, and the US.
TympaHealth provides an all-in-one ear and hearing health assessment platform designed to widen access to diagnostics across clinical and community settings.
TympaHealth has secured £5.9m in a seed financing round to accelerate its commercial expansion across the UK, Europe, and United States markets. The funding was led by serial healthcare entrepreneurs Maurice Ferre and Arjun Desai, alongside participants including Jim Breyer, Anil Sethi, Martin Varsavsky, Carlos Gallardo, Fred Moll, Elan Katz, Manny Kadre, Imran Hakim, and KHP MedTech Innovations.
Founded by Dr. Krishan Ramdoo, the company has built a portable platform combining hardware and AI-enabled software to allow ear drum visualisation, wax removal, and audiogram screening outside traditional clinical environments. The fresh capital will support the business as it scales its reach into pharmacies, retail stores, and assisted living facilities.
The company has also appointed Arjun Desai and Karin Ajmani to its board of directors to guide its ongoing international growth and strategic development.
Use of funds
- 01Expand into international markets
Investors
Maurice Ferre
Arjun Desai
Jim Breyer
Anil Sethi
Martin Varsavsky
Carlos Gallardo
Fred Moll
Elan Katz
Manny Kadre
Imran Hakim
KHP MedTech Innovations
Categories
About the company
TympaHealth
TympaHealth develops a digital ear and hearing health assessment platform.